DK156646C - Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf - Google Patents

Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf

Info

Publication number
DK156646C
DK156646C DK326377A DK326377A DK156646C DK 156646 C DK156646 C DK 156646C DK 326377 A DK326377 A DK 326377A DK 326377 A DK326377 A DK 326377A DK 156646 C DK156646 C DK 156646C
Authority
DK
Denmark
Prior art keywords
ammonius
ammoniumals
pyrrolidylmethyl
oms
sulfamoyl
Prior art date
Application number
DK326377A
Other languages
Danish (da)
English (en)
Other versions
DK326377A (da
DK156646B (da
Inventor
Michel Leon Thominet
Jacques Perrot
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DK326377A publication Critical patent/DK326377A/da
Publication of DK156646B publication Critical patent/DK156646B/da
Application granted granted Critical
Publication of DK156646C publication Critical patent/DK156646C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK326377A 1976-07-19 1977-07-18 Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf DK156646C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
FR7622180 1976-07-19

Publications (3)

Publication Number Publication Date
DK326377A DK326377A (da) 1978-01-20
DK156646B DK156646B (da) 1989-09-18
DK156646C true DK156646C (da) 1990-02-05

Family

ID=9175947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK326377A DK156646C (da) 1976-07-19 1977-07-18 Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf

Country Status (38)

Country Link
US (1) US4499019A (US07696358-20100413-C00002.png)
JP (1) JPS5338631A (US07696358-20100413-C00002.png)
AR (1) AR214330A1 (US07696358-20100413-C00002.png)
AT (1) AT365570B (US07696358-20100413-C00002.png)
AU (1) AU509291B2 (US07696358-20100413-C00002.png)
BE (1) BE856289A (US07696358-20100413-C00002.png)
CH (1) CH627162A5 (US07696358-20100413-C00002.png)
CS (1) CS219885B2 (US07696358-20100413-C00002.png)
CY (1) CY1036A (US07696358-20100413-C00002.png)
DD (2) DD137670A5 (US07696358-20100413-C00002.png)
DK (1) DK156646C (US07696358-20100413-C00002.png)
EG (1) EG12911A (US07696358-20100413-C00002.png)
ES (1) ES460621A1 (US07696358-20100413-C00002.png)
FI (1) FI67213C (US07696358-20100413-C00002.png)
FR (1) FR2358892A1 (US07696358-20100413-C00002.png)
GB (1) GB1539319A (US07696358-20100413-C00002.png)
GR (1) GR60836B (US07696358-20100413-C00002.png)
HK (1) HK17880A (US07696358-20100413-C00002.png)
HU (1) HU174981B (US07696358-20100413-C00002.png)
IE (1) IE46171B1 (US07696358-20100413-C00002.png)
IL (1) IL52547A (US07696358-20100413-C00002.png)
IN (1) IN146993B (US07696358-20100413-C00002.png)
LU (1) LU77782A1 (US07696358-20100413-C00002.png)
MC (1) MC1153A1 (US07696358-20100413-C00002.png)
MX (1) MX4711E (US07696358-20100413-C00002.png)
NL (1) NL174347C (US07696358-20100413-C00002.png)
NO (1) NO146598C (US07696358-20100413-C00002.png)
NZ (1) NZ184634A (US07696358-20100413-C00002.png)
OA (1) OA05704A (US07696358-20100413-C00002.png)
PH (1) PH12838A (US07696358-20100413-C00002.png)
PL (1) PL104244B1 (US07696358-20100413-C00002.png)
PT (1) PT66819B (US07696358-20100413-C00002.png)
RO (1) RO71691A (US07696358-20100413-C00002.png)
SE (1) SE425243B (US07696358-20100413-C00002.png)
SU (1) SU695556A3 (US07696358-20100413-C00002.png)
YU (1) YU40677B (US07696358-20100413-C00002.png)
ZA (1) ZA774256B (US07696358-20100413-C00002.png)
ZM (1) ZM5477A1 (US07696358-20100413-C00002.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
AU509291B2 (en) 1980-05-01
CH627162A5 (US07696358-20100413-C00002.png) 1981-12-31
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04
PH12838A (en) 1979-09-05
FI67213C (fi) 1985-02-11
FI67213B (fi) 1984-10-31
DD137670A5 (de) 1979-09-19
RO71691A (ro) 1982-09-09
NO146598C (no) 1982-11-03
IE46171B1 (en) 1983-03-23
AU2702677A (en) 1979-01-18
SE7708176L (sv) 1978-01-20
ES460621A1 (es) 1978-05-01
FR2358892A1 (fr) 1978-02-17
NL174347C (nl) 1984-06-01
FI772214A (US07696358-20100413-C00002.png) 1978-01-20
SE425243B (sv) 1982-09-13
PL199723A1 (pl) 1978-04-24
PL104244B1 (pl) 1979-08-31
ATA511677A (de) 1981-06-15
PT66819B (fr) 1978-12-22
ZM5477A1 (en) 1978-05-22
ZA774256B (en) 1978-06-28
AR214330A1 (es) 1979-05-31
IL52547A0 (en) 1977-10-31
US4499019A (en) 1985-02-12
AT365570B (de) 1982-01-25
OA05704A (fr) 1981-05-31
NL174347B (nl) 1984-01-02
IL52547A (en) 1980-01-31
NO772530L (no) 1978-01-20
YU40677B (en) 1986-04-30
JPS554724B2 (US07696358-20100413-C00002.png) 1980-01-31
NO146598B (no) 1982-07-26
MC1153A1 (fr) 1978-04-17
JPS5338631A (en) 1978-04-08
NZ184634A (en) 1978-11-13
SU695556A3 (ru) 1979-10-30
IE46171L (en) 1978-01-19
HK17880A (en) 1980-04-11
CS219885B2 (en) 1983-03-25
IN146993B (US07696358-20100413-C00002.png) 1979-10-20
NL7707982A (nl) 1978-01-23
DK326377A (da) 1978-01-20
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
EG12911A (en) 1980-12-31
MX4711E (es) 1982-08-11
DK156646B (da) 1989-09-18
GR60836B (en) 1978-08-31
HU174981B (hu) 1980-04-28
LU77782A1 (US07696358-20100413-C00002.png) 1977-10-17
PT66819A (fr) 1977-08-01
YU173977A (en) 1983-01-21
FR2358892B1 (US07696358-20100413-C00002.png) 1978-12-15

Similar Documents

Publication Publication Date Title
DK144010C (da) Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf
DK405477A (da) Fremgangsmaade til fremstilling af 5-alkoxyimidazo(1,2-a) quinolin-2-carboxylsyrer eller estere eller kationiske salte deraf
DK520077A (da) Fremgangsmaade til fremstilling af 5-(hydroxysubstitueret-methhyl)-2,3-dihydrobenzofuran-2-carboxylsyrer eller salte estere eller amider deraf
DK392877A (da) Fremgangsmaade til fremstilling af phenylethylaminer eller syreadditionssalte heraf
DK45081A (da) Fremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl) )--imidazolin eller ikke-toxiske syreadditionssalte deraf
DK160045C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK118482A (da) Fremgangsmaade til fremstilling af 2,4,5-trisubstituerede thiazoler eller salte deraf
DK145019C (da) Analogifremgangsmaade til fremstilling af (3,5-diamino-6-fluorpyrazinoyl)guanidin eller syreadditionssalte deraf
DK296477A (da) Fremgangsmade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinylidenbenzamin eller syreadditionssalte heraf
DK156646C (da) Analogifremgangsmaade til fremstilling af n-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoyl-benzamid eller syreadditionssalte, kvaternaere ammoniumsalte, n-oxider eller optisk aktive isomere deraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK20077A (da) Fremgangsmade til fremstilling af salte af 3,3-dimethyl-2-oxo-smorsyre
DK140695B (da) Analogifremgangsmaade til fremstilling af 2,4-diamo-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK312477A (da) Fremgangsmade til fremstilling af basisk substituerede phenylacetonitriler eller syreadditionssalte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK86485D0 (da) Fremgangsmaade til fremstilling af n-(4-(3-aminopropyl)-aminobutyl)-2,2-dihydroxyethanamid eller syreadditionssalte deraf
DK144912C (da) Fremgangsmaade til fremstilling af substituerede 2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxociner
DK142578C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner og syreadditionssalte deraf
DK144916C (da) Fremgangsmaade til fremstilling af vlb-3-spiro-5"-oxazolidin-2",4"-dion eller ikke-toxiske syreadditionssalte heraf
DK138265B (da) Analogifremgangsmåde til fremstilling af 4,4-diaryl-2-hydroxybutylaminer eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK351880A (da) Fremgangsmaade til fremstilling af tetrahydroquinoliner eller syreadditionssalte deraf
DK152501C (da) Fremgangsmaade til fremstilling af pyrrolooe1,2-aaapyrimidiner eller salte deraf
DK153539C (da) Fremgangsmaade til fremstilling af 3,3-dimethyl-2-oxosmoersyre eller salte deraf

Legal Events

Date Code Title Description
PUP Patent expired